Park Medi World IPO GMP History
Park Medi World IPO has been listed on December 17, 2025 at a listing price of ₹158.80, against the issue price of ₹162 — a loss of ₹3.2 (-1.98%). The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Park Medi World IPO raised ₹920 Cr. through its IPO at a price band of ₹154 – 162 per share, with a lot size of 92 shares. The IPO was open for subscription from 10 Dec 2025 to 12 Dec 2025.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 27 Aug, 12:08 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| No GMP history available yet. | |||||
Park Medi World IPO dates
Key dates from opening to listing. Today is 17 October.
- Open 10 Dec 2025
- Close 12 Dec 2025
- Allotment 16 Dec 2025
- Refund/credit 16 Dec 2025
- Listing 17 Dec 2025
Park Medi World IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹162 |
|---|---|
| Listing gain / loss | −₹3.2 per share |
| Listing date | 17 Dec, 2025 |
| Actual listing price | ₹158.80 (-1.98%) |
Is Park Medi World IPO GMP reliable?
Grey market premium for Park Medi World IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Park Medi World IPO full review for a fundamentals-based assessment before making any grey market trades.
Park Medi World IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Park Medi World IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Park Medi World IPO
Park Medi World is an India-based healthcare company engaged in providing a range of medical products and services to hospitals, clinics, and healthcare institutions. The company was established with the objective of improving accessibility to quality medical supplies and healthcare solutions. Over the years, it has built a presence in the healthcare distribution space by focusing on reliability, timely delivery, and strong vendor relationships. The promoters bring industry experience and have played a key role in expanding the company’s operations and strengthening its network across multiple regions.
The company offers a diversified portfolio that includes medical consumables, surgical instruments, diagnostic products, and other healthcare-related supplies. Its business model is largely based on sourcing products from manufacturers and supplying them to institutional clients, ensuring consistent demand and repeat business. Park Medi World focuses on maintaining quality standards and competitive pricing to serve its clients efficiently. By leveraging its distribution network and industry connections, the company aims to achieve steady growth and expand its footprint in the Indian healthcare sector.
Frequently asked
What is the GMP of Park Medi World IPO?
The current Grey Market Premium (GMP) of Park Medi World IPO is not yet started or active in the market.
What is the Kostak Price of Park Medi World IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Park Medi World IPO is not available.
What is the Subject to Sauda Price of Park Medi World IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Park Medi World IPO?
Park Medi World IPO listed on December 17, 2025 at ₹158.80, against the issue price of ₹162 — a loss of -1.98%.
How did the GMP of Park Medi World IPO trend before listing?
The GMP of Park Medi World IPO was stable in its final days before listing. View the day-wise table above for the complete GMP history.
Explore Park Medi World IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
